Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1978 Aug;41(8):699–701. doi: 10.1136/jnnp.41.8.699

Histocompatibility antigens (HLA) in multiple sclerosis in Iran.

J Lotfi, B Nikbin, I Derakhshan, Z Aghai, F Ala
PMCID: PMC1083383  PMID: 681957

Abstract

Thirty-five patients (19 male and 16 female) with clinically definite multiple sclerosis and 100 healthy control subjects were studied for the A and B locus of the HLA system. A significant increase of HLA A3 and A11 of the A locus and B7 of the B locus was observed in patients with multiple sclerosis compared with controls. An increase of antigen A3 was also observed in eight cases of probable multiple sclerosis. A significant increase of both A3 and B7 was observed in patients with multiple sclerosis.

Full text

PDF
699

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertrams H. J., Kuwert E. K. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis. J Immunol. 1976 Nov;117(5 PT2):1906–1912. [PubMed] [Google Scholar]
  2. Bertrams J., Kuwert E., Liedtke U. HL-A antigens and multiple sclerosis. Tissue Antigens. 1972;2(5):405–408. doi: 10.1111/j.1399-0039.1972.tb00060.x. [DOI] [PubMed] [Google Scholar]
  3. Brautbar C., Alter M., Kahana E. HLA antigens in multiple sclerosis. Neurology. 1976 Jun;26(6 Pt 2):50–53. doi: 10.1212/wnl.26.6_part_2.50. [DOI] [PubMed] [Google Scholar]
  4. Compston D. A., Batchelor J. R., McDonald W. I. B-lymphocyte alloantigens associated with multiple sclerosis. Lancet. 1976 Dec 11;2(7998):1261–1265. doi: 10.1016/s0140-6736(76)92027-4. [DOI] [PubMed] [Google Scholar]
  5. Jersild C., Fog T., Hansen G. S., Thomsen M., Svejgaard A., Dupont B. Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet. 1973 Dec 1;2(7840):1221–1225. doi: 10.1016/s0140-6736(73)90970-7. [DOI] [PubMed] [Google Scholar]
  6. Jersild C., Svejgaard A., Fog T., Ammitzboll T. HL-A antigens and diseases. I. Multiple sclerosis. Tissue Antigens. 1973;3(4):243–250. doi: 10.1111/j.1399-0039.1973.tb01002.x. [DOI] [PubMed] [Google Scholar]
  7. Kurtzke J. F. Geography in multiple sclerosis. J Neurol. 1977 Apr 28;215(1):1–26. doi: 10.1007/BF00312546. [DOI] [PubMed] [Google Scholar]
  8. McDonald W. I., Halliday A. M. Diagnosis and classification of multiple sclerosis. Br Med Bull. 1977 Jan;33(1):4–9. [PubMed] [Google Scholar]
  9. Saito S., Naito S., Kawanami S., Kurowa Y. HLA studies on multiple sclerosis in Japan. Neurology. 1976 Jun;26(6 Pt 2):49–49. doi: 10.1212/wnl.26.6_part_2.49. [DOI] [PubMed] [Google Scholar]
  10. Terasaki P. I., Mickey M. R. A single mutation hypothesis for multiple sclerosis based on the HL-A system. Neurology. 1976 Jun;26(6 Pt 2):56–58. doi: 10.1212/wnl.26.6_part_2.56. [DOI] [PubMed] [Google Scholar]
  11. Terasaki P. I., Mickey M. R. HL-A haplotypes of 32 diseases. Transplant Rev. 1975;22:105–119. doi: 10.1111/j.1600-065x.1975.tb01553.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES